"It is often assumed individuals using hemp-derived products will test negative for THC. Current results indicate this may not be true."
"This case series suggests that CBD may have antinociceptive and anti-inflammatory effects [in] patients with neuropathic and radicular pain."
A spokesperson for New Zealand NORML said, "[W]ith such a close vote, we will need compromise and consensus."
Overall, voters decided on 38 measures in 36 cities or counties.
"We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement."
Researchers identified "no association between past-year cannabis use and work-related injury" for employees in any occupation.
"To the best of our knowledge, the first study analyzing the role of cannabinoids in the management of unresponsive BMS."
The in vivo conversion of CBD to Δ9-THC is not supported by the majority of human or animal studies, investigators concluded.